Welcome to our dedicated page for JBS N.V. SEC filings (Ticker: JBS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
JBS N.V. filings document the reporting of a foreign private issuer with common shares listed on the NYSE and Brazilian depositary receipts referenced in shareholder materials. The record includes Form 6-K current reports, Form 20-F annual-report notices, audited consolidated financial statements, IFRS operating results, liquidity and capital resources, capital-structure information and dividend disclosures.
JBS filing exhibits also cover annual general meeting materials, shareholder voting results, board composition matters, director reappointments, adoption of annual accounts and discussion of the Dutch Corporate Governance Code. Investor presentations and earnings releases describe the company's global protein operations, reportable segments, forward-looking statement assumptions and financial performance across its food production and branded product portfolio.
JBS N.V. has called its 2026 annual general meeting for April 30, 2026 in Amsterdam, setting out agenda items on 2025 results, governance and capital authorizations. The Board will present 2025 financial and non-financial performance and propose adoption of the 2025 annual accounts audited by KPMG.
The Board confirmed that 2025 profits will be added to reserves, while a previously approved dividend of US$ 1 per share from distributable reserves is scheduled for payment on June 17, 2026 to shareholders of record on May 18, 2026. Shareholders are also asked to grant discharge to directors for 2025 performance and to reappoint a broad slate of executive and non-executive directors, including the CEO, chairman and several independent board members.
KPMG Accountants N.V. is proposed for reappointment as external auditor for 2026. The Board seeks fresh 18‑month authorizations to issue up to 10% of issued share capital, to limit or exclude pre‑emptive rights up to the same level, to repurchase up to 10% of Class A shares and BDRs within defined price bands, and to cancel repurchased shares. The notice also details record date, registration, proxy and voting procedures for shareholders and Brazilian depositary receipt holders.
JBS N.V. has priced an international debt offering totaling US$2 billion in senior notes. The company and its U.S. subsidiaries will issue US$1.25 billion 2037 notes with a 5.625% coupon and US$750 million 2057 notes with a 6.400% coupon, with settlement scheduled for April 13, 2026.
Net proceeds are expected to be used primarily to fund cash tender offers for up to US$1.0 billion of existing 6.750% notes due 2034 and 5.950% notes due 2035, and for general corporate purposes, effectively refinancing part of JBS’s long-term debt profile.
JBS N.V. has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025. The filing includes the company’s audited consolidated financial statements for the year ended December 31, 2025 and was submitted to the SEC on March 25, 2026.
The report is available on both the SEC’s website and JBS’s investor relations website. Shareholders and investors can also request a hard copy of the report free of charge by contacting the company via phone or email.
JBS N.V. reported strong fourth quarter and fiscal 2025 results and approved a cash dividend of US$ 1 per share, payable on June 17, 2026 to shareholders of record on May 18, 2026.
For 2025, net sales reached $86,184.2 million, up from $77,182.5 million in 2024, while net income attributable to JBS rose to $2,024.3 million from $1,766.9 million. Earnings per share increased to $1.89 from $1.65. Under IFRS, Adjusted EBITDA was $6,831.4 million versus $7,191.9 million, with margin declining from 9.3% to 7.9%.
The company highlighted record sales in multiple segments, including JBS Beef North America, JBS Brazil, Seara, JBS USA Pork and JBS Australia, alongside diversified performance across geographies and proteins. Free cash flow totaled $989.8 million in the fourth quarter and $400.2 million for the year. Return on equity reached 25.3%, return on invested capital was 17.4%, and Net Debt / Adjusted EBITDA ended 2025 at 2.39x, compared with 1.89x a year earlier.
JBS N.V. files its annual report as a Dutch holding company for JBS S.A. after a June 2025 corporate restructuring accounted for as a common control transaction under IFRS. The group presents consolidated financial statements in U.S. dollars, with extensive use of Adjusted EBITDA as a non‑GAAP performance metric.
As of December 31, 2025, JBS N.V. reports 773,666,610 Class A and 294,842,267 Class B common shares outstanding. The report outlines wide‑ranging risks: volatile livestock and feed costs, exposure to animal disease and food safety events, contamination and recall risk, strong competition, and capital‑intensive growth.
Additional risks include ESG and deforestation compliance (notably in Brazil and under the EU Deforestation Regulation), significant legal exposures, worker‑safety and labor issues, cyber‑security threats, and heavy influence from controlling shareholders through a dual‑class structure. JBS N.V. also discloses a material weakness in internal control over financial reporting related to IT general controls and highlights the added complexity and cost of U.S. public‑company and foreign private issuer obligations.
JBS N.V. Global CFO and IRO Guilherme Perboyre Cavalcanti filed an initial insider report listing his direct equity interests. He holds 183,501 Class A Common Shares, plus restricted stock units linked to 59,589, 74,074, 238,884 and 1,139,914 underlying Class A shares, each subject to future vesting schedules.
JBS N.V. director Meirelles Henrique C has filed an initial Form 3 statement of beneficial ownership. The filing, as summarized in the available data, reports no buy or sell transactions, no derivative transactions, and no outstanding derivative positions for this reporting person.
JBS N.V. director Raul Padilla filed an initial ownership report showing his existing stake in the company. The Form 3 lists direct ownership of 55,000 Class A Common Shares following the reported holdings. This filing records his current position and does not reflect a new purchase or sale.
JBS N.V. director Vasconcelos Araujo Carlos Hamilton filed an initial ownership report showing beneficial ownership of 5,000 Class A Common Shares. These are held as Brazilian Depositary Receipts, with each BDR representing one Class A Common Share, and are reported as directly owned.
JBS N.V.’s Global CEO, Gilberto Tomazoni, has reported his initial equity holdings. The filing shows direct ownership of 5,858,958 Class A Common Shares. It also reports 1,519,885 restricted stock units, each representing the right to receive one Class A Common Share, vesting in stages from August 1, 2027 through August 1, 2029, subject to continued employment.